Loading...
Driving performance
of nebulizer therapy
through our
Innovative
Breath-
Guiding
Concept
Flow resistance
for optimized breathing patterns (Fluidic Diode)
Real-time breath-guiding via
visual and haptic feedback on device and app
Inhalation report & educational content in the app
Integration
1
Outstanding Efficiency
Combination of excellent delivered dose and high respirable fraction.
Short
Nebulization Time
Critical factor to ensure patient acceptance
Efficiency driven by
Adjustable particle size (customization)
Breath-guiding features to support ideal breathing patterns
Integration
2
Advanced Usability
Ergonomic Design
based on several human factors studies
Smartphone App
and patient adherence
Comprehensive instructions for operating the device
Continuous breath-guiding to support consistent inhalation outcomes
Detailed insights and feedback after every inhalation
Smartphone App
Real-time feedback
and therapy planning
for increased motivation
and patient adherence
Comprehensive
instructions
for operating
the device
Continuous
breath-guiding
to support consistent
outcomes
Detailed insights
and feedback
after every inhalation
Considering usability requirements
Appropriate device size and ergonomic holding position
Breath-guiding features for patient comfort and reassurance
Integration
3
Innovative
& Proven
Benefit from latest PARI technologies while relying on more than 20 years of clinical and commercial experience through both
Innovative
Concept
Innovative real-time breath-guiding
Innovative product design
all based on
Established eFlow Technology Platform
Track Record
2010
Altera® for Cayston®
Gilead Sciences Inc. • US, EU, CAN
2015
Zirela® for QUINSAIR™
Horizon • CAN, EU
Tolero® for Vantobra®
PARI Pharma • EU
2018 - 2021
Lamira® for ARIKAYCE®
Insmed Incorporated • EU, JPN, US
Pipeline
High Quality Manufacturing
Use of existing, reliable manufacturing and development processes at several PARI sites.
All integrated into one device platform.